D-0168-2021 Class I Terminated
FDA drug recall D-0168-2021 was initiated by AVKARE Inc. on Dec 7, 2020 and is designated Class I. Reason for recall: Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility. The recall status is terminated (terminated Oct 16, 2023). Affected quantity: 14368 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 23, 2020
- Initiation Date
- Dec 7, 2020
- Termination Date
- Oct 16, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14368 bottles
Product description
TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10
Reason for recall
Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Distribution pattern
Nationwide within the U.S.
Code information
Lot: 36783 Exp. 06/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0168-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026